Sarepta names Michael Severino CEO, succeeding retiring Doug Ingram

Reuters2026/07/27 12:31

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Sarepta appointed Michael Severino as CEO, effective July 28, 2026.
Severino was previously CEO of Tessera Therapeutics.
He earlier served as vice chairman, president at AbbVie, leading R&D, corporate strategy.
Severino will join the board; Doug Ingram will retire, remain an adviser through end-2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sarepta Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260727284554) on July 27, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Sarepta names Michael Severino CEO, succeeding retiring Doug Ingram

You may also like

Crypto prices